ML18037B126: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(5 intermediate revisions by the same user not shown)
Line 3: Line 3:
| issue date = 02/06/2018
| issue date = 02/06/2018
| title = NRC Staff Revised Exhibit List
| title = NRC Staff Revised Exhibit List
| author name = Wachutka J L, Young M A
| author name = Wachutka J, Young M
| author affiliation = NRC/OGC
| author affiliation = NRC/OGC
| addressee name =  
| addressee name =  
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )  
{{#Wiki_filter:February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of                                 )
) NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP )  
                                                  )
(Medical Radioisotope Production Facility) )  
NORTHWEST MEDICAL ISOTOPES, LLC                   )     Docket No. 50-609-CP
)
                                                  )
NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, "NRC Staff Responses to Commission Post-Hearing Questions," which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014. Respectfully submitted, /Signed (electronically) by/       Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d) Jeremy L. Wachutka       Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9188 E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018 Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018) Exhibit Number Sponsoring Witness(es) Document Description/Title NRC-001 MaryJane Ross-Lee and Joseph Donoghue SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037). NRC-002 MaryJane Ross-Lee Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018). NRC-003 Joseph Donoghue Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.
(Medical Radioisotope Production Facility)       )
17, 2017) (ADAMS Accession No. ML17313A338)  
                                                  )
(revised Jan. 16, 2018). NRC-004 MaryJane Ross-Lee and Joseph Donoghue NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554). NRC-005 MaryJane Ross-Lee and Joseph Donoghue NON-PUBLIC - NRC Staff Responses to Non-Public Pre-Hearing Questions and Non-Public Response to Question 36 (Jan. 2, 2018) (ADAMS Accession No. ML18002A546). NRC-006A MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in part)). NRC-006B MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.
NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, NRC Staff Responses to Commission Post-Hearing Questions, which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014.
ML17257A022 and ML17257A023). NRC-006C MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No.
Respectfully submitted,
ML17257A024). NRC-006D MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025). NRC-006E MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively). NRC-006F MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033). NRC-006G MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively). NRC-006H Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.
                                              /Signed (electronically) by/
Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d)
Jeremy L. Wachutka Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9188 E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018
 
Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018)
Exhibit         Sponsoring                    Document Description/Title Number         Witness(es)
NRC-001     MaryJane Ross-Lee     SECY-17-0116, Staff Statement in Support of the and Joseph Donoghue    Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037).
NRC-002     MaryJane Ross-Lee     Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018).
NRC-003     Joseph Donoghue       Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.
17, 2017) (ADAMS Accession No. ML17313A338)
(revised Jan. 16, 2018).
NRC-004     MaryJane Ross-Lee     NRC Staff Revised Responses to Commission Pre-and Joseph Donoghue    Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554).
NRC-005     MaryJane Ross-Lee     NON-PUBLIC - NRC Staff Responses to Non-and Joseph            Public Pre-Hearing Questions and Non-Public Donoghue              Response to Question 36 (Jan. 2, 2018) (ADAMS Accession No. ML18002A546).
NRC-006A   MaryJane Ross-Lee     Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in part)).
NRC-006B   MaryJane Ross-Lee     Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.
ML17257A022 and ML17257A023).
NRC-006C   MaryJane Ross-Lee     Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A024).
NRC-006D   MaryJane Ross-Lee     Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025).
NRC-006E   MaryJane Ross-Lee     Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively).
 
NRC-006F MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033).
NRC-006G MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively).
NRC-006H Joseph Donoghue   Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.
OA, Chapter 19, Beginning through 19-130 (Jun.
OA, Chapter 19, Beginning through 19-130 (Jun.
2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131). NRC-006I Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. OA, Chapter 19, 19-131 through End (Jun. 2015)  
2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131).
(ADAMS Accession Nos. ML15210A128 and ML15210A129). NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)). NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)  
NRC-006I Joseph Donoghue   Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.
(ADAMS Accession Nos. ML17257A044 and ML17257A045). NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046). NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047). NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)  
OA, Chapter 19, 19-131 through End (Jun. 2015)
(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively). NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 9 through 11 (Sep.
(ADAMS Accession Nos. ML15210A128 and ML15210A129).
2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively). NRC-007G MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 12 through 13 (Sep.
NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)).
2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056). NRC-007H MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively). NRC-007I Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos. ML15211A223 and ML15211A224). NRC-007J Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, 19-109 through End (Jun. 2015) (ADAMS Accession Nos.
NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)
ML15211A225 and ML15211A226). NRC-008 MaryJane Ross-Lee Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as revised Jan. 2018). NRC-009 Joseph Donoghue NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)  
(ADAMS Accession Nos. ML17257A044 and ML17257A045).
(ADAMS Accession No. ML17130A862). NRC-010 MaryJane Ross-Lee and Joseph Donoghue Staff Presentation Slides - Overview (Jan. 16, 2018). (ADAMS Accession No. ML18016BA074) NRC-011 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018). NRC-012 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018). NRC-013 Joseph Donoghue Staff Presentation Slides - Environmental Panel (Jan. 16, 2018). NRC-014 MaryJane Ross-Lee, Joseph Donoghue and Brian Smith NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018)
NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046).
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION  BEFORE THE COMMISSION  In the Matter of )
NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047).
)
NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)
NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP
(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively).
) (Medical Radioisotope Production Facility) )  )
NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 9 through 11 (Sep.
2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively).
 
NRC-007G MaryJane Ross-Lee   NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 12 through 13 (Sep.
2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056).
NRC-007H MaryJane Ross-Lee   NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep.
2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively).
NRC-007I Joseph Donoghue     NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos.
ML15211A223 and ML15211A224).
NRC-007J Joseph Donoghue     NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, 19-109 through End (Jun. 2015) (ADAMS Accession Nos.
ML15211A225 and ML15211A226).
NRC-008 MaryJane Ross-Lee   Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017)
(ADAMS Accession No. ML18016A021) (as revised Jan. 2018).
NRC-009 Joseph Donoghue     NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)
(ADAMS Accession No. ML17130A862).
NRC-010 MaryJane Ross-Lee   Staff Presentation Slides - Overview (Jan. 16, 2018).
and Joseph Donoghue (ADAMS Accession No. ML18016BA074)
NRC-011 MaryJane Ross-Lee   Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018).
NRC-012 MaryJane Ross-Lee   Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018).
NRC-013 Joseph Donoghue     Staff Presentation Slides - Environmental Panel (Jan.
16, 2018).
NRC-014 MaryJane Ross-Lee,  NRC Staff Responses to Commission Post-Hearing Joseph Donoghue and Questions (Feb. 6, 2018)
Brian Smith


CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing "NRC STAFF REVISED EXHIBIT LIST," dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRC's E-Filing System, in the above-captioned proceeding, this 6th day of February, 2018.  
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of                                  )
/Signed (electronically) by/       Mitzi A. Young       Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018}}
                                                  )
NORTHWEST MEDICAL ISOTOPES, LLC                  )    Docket No. 50-609-CP
                                                  )
(Medical Radioisotope Production Facility)        )
                                                  )
CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing NRC STAFF REVISED EXHIBIT LIST, dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRCs E-Filing System, in the above-captioned proceeding, this 6th day of February, 2018.
                                            /Signed (electronically) by/
Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018}}

Latest revision as of 16:16, 3 February 2020

NRC Staff Revised Exhibit List
ML18037B126
Person / Time
Site: Northwest Medical Isotopes
Issue date: 02/06/2018
From: Jeremy Wachutka, Matt Young
NRC/OGC
To:
NRC/OCM
SECY RAS
References
Construction Permit Mndtry Hrg, M 50-609-CP, RAS 54217
Download: ML18037B126 (5)
v • d • e


Text

February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )

)

NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP

)

(Medical Radioisotope Production Facility) )

)

NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, NRC Staff Responses to Commission Post-Hearing Questions, which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014.

Respectfully submitted,

/Signed (electronically) by/

Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d)

Jeremy L. Wachutka Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9188 E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018

Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018)

Exhibit Sponsoring Document Description/Title Number Witness(es)

NRC-001 MaryJane Ross-Lee SECY-17-0116, Staff Statement in Support of the and Joseph Donoghue Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037).

NRC-002 MaryJane Ross-Lee Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018).

NRC-003 Joseph Donoghue Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.

17, 2017) (ADAMS Accession No. ML17313A338)

(revised Jan. 16, 2018).

NRC-004 MaryJane Ross-Lee NRC Staff Revised Responses to Commission Pre-and Joseph Donoghue Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554).

NRC-005 MaryJane Ross-Lee NON-PUBLIC - NRC Staff Responses to Non-and Joseph Public Pre-Hearing Questions and Non-Public Donoghue Response to Question 36 (Jan. 2, 2018) (ADAMS Accession No. ML18002A546).

NRC-006A MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in part)).

NRC-006B MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.

ML17257A022 and ML17257A023).

NRC-006C MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A024).

NRC-006D MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025).

NRC-006E MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively).

NRC-006F MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033).

NRC-006G MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively).

NRC-006H Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.

OA, Chapter 19, Beginning through 19-130 (Jun.

2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131).

NRC-006I Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.

OA, Chapter 19,19-131 through End (Jun. 2015)

(ADAMS Accession Nos. ML15210A128 and ML15210A129).

NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)).

NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)

(ADAMS Accession Nos. ML17257A044 and ML17257A045).

NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046).

NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047).

NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)

(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively).

NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 9 through 11 (Sep.

2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively).

NRC-007G MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 12 through 13 (Sep.

2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056).

NRC-007H MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep.

2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively).

NRC-007I Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos.

ML15211A223 and ML15211A224).

NRC-007J Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19,19-109 through End (Jun. 2015) (ADAMS Accession Nos.

ML15211A225 and ML15211A226).

NRC-008 MaryJane Ross-Lee Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017)

(ADAMS Accession No. ML18016A021) (as revised Jan. 2018).

NRC-009 Joseph Donoghue NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)

(ADAMS Accession No. ML17130A862).

NRC-010 MaryJane Ross-Lee Staff Presentation Slides - Overview (Jan. 16, 2018).

and Joseph Donoghue (ADAMS Accession No. ML18016BA074)

NRC-011 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018).

NRC-012 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018).

NRC-013 Joseph Donoghue Staff Presentation Slides - Environmental Panel (Jan.

16, 2018).

NRC-014 MaryJane Ross-Lee, NRC Staff Responses to Commission Post-Hearing Joseph Donoghue and Questions (Feb. 6, 2018)

Brian Smith

UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )

)

NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP

)

(Medical Radioisotope Production Facility) )

)

CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing NRC STAFF REVISED EXHIBIT LIST, dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRCs E-Filing System, in the above-captioned proceeding, this 6th day of February, 2018.

/Signed (electronically) by/

Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018

Retrieved from "https://kanterella.com/w/index.php?title=ML18037B126&oldid=2417759"